Dysbetalipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) |
||
| Line 9: | Line 9: | ||
=Screening= | =Screening= | ||
=Natural History, Complication, Prognosis= | =Natural History, Complication, Prognosis= | ||
==Complications== | |||
* Heart attack | |||
* Stroke | |||
* Peripheral vascular disease | |||
* Intermittent claudication | |||
* Gangrene of the lower extremities | |||
=Diagnosis= | =Diagnosis= | ||
=History and Symptoms= | =History and Symptoms= | ||
Revision as of 16:58, 9 November 2016
Overview
Classification
Historical perspective
Pathophysiology
Causes
Differential Diagnoses
Epidemiology and Demographics
Screening
Natural History, Complication, Prognosis
Complications
- Heart attack
- Stroke
- Peripheral vascular disease
- Intermittent claudication
- Gangrene of the lower extremities
Diagnosis
History and Symptoms
Physical Exam
Laboratory Findings
Molecular Genetic Testing
Treatment
Prevention
- Screening the family members of those with familial dysbetalipoproteinemia may lead to early detection and treatment.
- Early treatment and avoiding other risk factors for vascular disease (such as smoking) are crucial to preventing early heart attacks, strokes, and blocked blood vessels.